Literature DB >> 19540854

Fanconi anemia: a paradigm of discovering molecular pathways from patients.

Paul R Andreassen, Laura J Niedernhofer.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19540854      PMCID： PMC4928689          DOI： 10.1016/j.mrfmmm.2009.06.007

Source DB:  PubMed          Journal:  Mutat Res        ISSN： 0027-5107            Impact factor:   2.433


× No keyword cloud information.
  10 in total

1.  Disruption of the Fanconi anemia pathway in human cancer in the general population.

Authors:  Céline Jacquemont; Toshiyasu Taniguchi
Journal:  Cancer Biol Ther       Date:  2006-12-06       Impact factor: 4.742

2.  Mechanism of replication-coupled DNA interstrand crosslink repair.

Authors:  Markus Räschle; Puck Knipscheer; Puck Knipsheer; Milica Enoiu; Todor Angelov; Jingchuan Sun; Jack D Griffith; Tom E Ellenberger; Orlando D Schärer; Johannes C Walter
Journal:  Cell       Date:  2008-09-19       Impact factor: 41.582

Review 3.  Fanconi anaemia genes and susceptibility to cancer.

Authors:  C G Mathew
Journal:  Oncogene       Date:  2006-09-25       Impact factor: 9.867

Review 4.  Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.

Authors:  Alex Lyakhovich; Jordi Surralles
Journal:  Cancer Lett       Date:  2005-10-21       Impact factor: 8.679

5.  Fanconi anemia proteins stabilize replication forks.

Authors:  Lily Chien Wang; Stacie Stone; Maureen Elizabeth Hoatlin; Jean Gautier
Journal:  DNA Repair (Amst)       Date:  2008-09-25

6.  Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M.

Authors:  Thiyam Ramsing Singh; Sietske T Bakker; Sheba Agarwal; Michael Jansen; Elke Grassman; Barbara C Godthelp; Abdullah Mahmood Ali; Chang-hu Du; Martin A Rooimans; Qiang Fan; Kebola Wahengbam; Jurgen Steltenpool; Paul R Andreassen; David A Williams; Hans Joenje; Johan P de Winter; Amom Ruhikanta Meetei
Journal:  Blood       Date:  2009-05-07       Impact factor: 22.113

Review 7.  BRCA-FA pathway as a target for anti-tumor drugs.

Authors:  Rachel Litman; Rigu Gupta; Robert M Brosh; Sharon B Cantor
Journal:  Anticancer Agents Med Chem       Date:  2008-05       Impact factor: 2.505

Review 8.  Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy.

Authors:  Paul R Andreassen; Keqin Ren
Journal:  Curr Cancer Drug Targets       Date:  2009-02       Impact factor: 3.428

9.  DNA structure-induced recruitment and activation of the Fanconi anemia pathway protein FANCD2.

Authors:  A Sobeck; S Stone; M E Hoatlin
Journal:  Mol Cell Biol       Date:  2007-04-09       Impact factor: 4.272

Review 10.  Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome.

Authors:  E Gluckman; J E Wagner
Journal:  Bone Marrow Transplant       Date:  2007-12-17       Impact factor: 5.483
  10 in total
  1 in total

1.  MDC1 directs chromosome-wide silencing of the sex chromosomes in male germ cells.

Authors:  Yosuke Ichijima; Misako Ichijima; Zhenkun Lou; André Nussenzweig; R Daniel Camerini-Otero; Junjie Chen; Paul R Andreassen; Satoshi H Namekawa
Journal:  Genes Dev       Date:  2011-05-01       Impact factor: 11.361
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.